Skip to Main Content

Author Details

Charlotte F Kweldam
Anser Prostate Operation Clinic, Maasstad Hospital
2011
34
20
PMIDPaper TitleJournal TitlePublished Year
37032279Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer.Eur Urol Focus2023
37407736Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging.Virchows Arch2023
37140551Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve-sparing surgery.Histopathology2023
36190529Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern.World J Urol2022
35384019Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.Histopathology2022
35536200NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome.BJU Int2022
31439369Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.Eur Urol2020
31876580Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.Am J Surg Pathol2020
31904279Comparison of Tumor Volume Parameters on Prostate Cancer Biopsies.Arch Pathol Lab Med2020
32913202Automated detection of cribriform growth patterns in prostate histology images.Sci Rep2020
32542746Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens.Histopathology2020
32459716The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.Am J Surg Pathol2020
30528698Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.Urol Oncol2019
30565302Grading of prostate cancer: a work in progress.Histopathology2019
29094386Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7.Histopathology2018
29594028On cribriform prostate cancer.Transl Androl Urol2018
29295717Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.BMC Cancer2018
28530220Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.Mod Pathol2017
28173626Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.Int J Urol2017
28162815Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.Eur Urol2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
26233533Reply to Masaki Shiota and Akira Yokomizo's Letter to the Editor re: Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. Eur Urol 2015;67:981-5.Eur Urol2016
27353346Three-dimensional microscopic analysis of clinical prostate specimens.Histopathology2016
27522247Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.Eur J Cancer2016
26939875Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.Mod Pathol2016
27028587Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.Histopathology2016
24592810Neonatal head ultrasonography today: a powerful imaging tool!J Neuroimaging2015
25686826Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.Oncotarget2015
25484141Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer.Eur Urol2015
25060593Disease-specific death and metastasis do not occur in patients with Gleason score ⿤6 at radical prostatectomy.BJU Int2015
25189638Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.Mod Pathol2015
24771489Undecussated superior cerebellar peduncles and absence of the dorsal transverse pontine fibers: a new axonal guidance disorder?Cerebellum2014
25243131Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.Biomed Res Int2014
20888312The incidence of craniosynostosis in the Netherlands, 1997-2007.J Plast Reconstr Aesthet Surg2011
  • 1 - 34 of 34

Recommended Authors

University Health Network
Career Start Year 2019
Number of shared co-authors 9
University of Toronto
Career Start Year 2013
Number of shared co-authors 15
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 2
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 2
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 6
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 5
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 20
University of Oxford
Career Start Year 2007
Number of shared co-authors 21
University of Toronto
Career Start Year 2006
Number of shared co-authors 9
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 7
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 11
Northwestern University
Career Start Year 2003
Number of shared co-authors 9
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 9
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 19
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 7
University of Cambridge
Career Start Year 1999
Number of shared co-authors 8
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 8
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 7
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 9
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 10
Career Start Year 1995
Number of shared co-authors 16
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 14
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 7
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 9
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
University of Oxford
Career Start Year 1987
Number of shared co-authors 11
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 25
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 16
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 12

Collaborators

Erasmus MC Cancer Institute, University Medical Center
Co-authored papers 26
University Health Network, University of Toronto
Co-authored papers 18
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 13
Erasmus University Medical Center
Co-authored papers 8
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 5
Leiden University Medical Center
Co-authored papers 4
Erasmus Medical Center
Co-authored papers 3
Universitat Pompeu Fabra
Co-authored papers 2
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 2
University of Pennsylvania
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 2
University of Toronto
Co-authored papers 2
Erasmus MC Cancer Institute
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 1
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Emory University School of Medicine
Co-authored papers 1
University of Miami Miller School of Medicine
Co-authored papers 1
University of Toronto
Co-authored papers 1
The Hospital for Sick Children
Co-authored papers 1
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 1
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 1
CHU de Quebec-Universite Laval
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 1